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Abstract
Background: The Middle East is regarded as a secondary reservoir for OXA-48 and New Delhi metallo-β-lactamase
(NDM) carbapenemases. One of the main challenges in clinical microbiology diagnostics is the detection of
carbapenemases. For this reason simple screening methods have been sought to detect carbapenemase
producers to determine appropriate therapeutic measures and implement infection control interventions. The
present study aimed to evaluate the efficacy of the modified Hodge test (MHT) and a boronic acid-based
combined disk test using carbapenems as substrates for the phenotypic determination of OXA-48 and NDM
type carbapenemases in 45 epidemiologically unrelated carbapenem-resistant clinical isolates of Klebsiella
pneumoniae (13 isolates), Acinetobacter baumanii (20 isolates), and Pseudomonas aeruginosa (12 isolates).
Results: Boronic acid disk test using meropenem as substrate and 600 µg of 3- aminophenylboronic acid (APB) was the
most sensitive method (83.33 %) for detection of OXA-48, while the most specific method was MHT (100 %). As regards
NDM carbapenemase, boronic acid disk tests using imipenem and 600 µg of APB per disk, and meropenem with 300 or
600 µg of APB were the most sensitive methods (87.50 %), while the most specific method was the MHT (100 %).
Conclusions: The results of the present study indicate that phenotypic screening with the MHT and the boronic acid
disk test may be used to detect OXA-48 and NDM carbapenemases in Gram-negative bacilli clinical isolates, and that
these tests can be easily applied in tertiary care settings with minimal infrastructure.
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Background
The emergence of carbapenemase-producing, Gram-
negative bacilli (GNB) has become an emerging public
health problem worldwide [1]. The emergence of GNB
may lead to variable levels of carbapenem resistance, as
well as to resistance to all β-lactam drugs, thereby lead-
ing to fewer options for treating such infections, which
have mortality rates as high as 50 % [2, 3]. Moreover,
carbapenemases-encoding genes are harbored in genetically
mobile elements, which allows their rapid spread between
GNB [4]. It has been postulated that the spread of
extended-spectrum β-lactamase (ESBL) producers was an
important factor that led to the increased use of carbapen-
ems, which has enhanced the selection of carbapenemase
producers [5, 6].
The currently widespread carbapenemases are the rapid
class A carbapenemases of the Klebsiella pneumoniae car-
bapenemase (KPC) type, the class B carbapenemases of
the New Delhi metallo-β-lactamase (NDM)-1 type, the
imipenem (IMP), and the Verona integron-encoded
metallo-β-lactamase types, and the class D carbapene-
mases of the OXA-48 type [2]. The Middle East is
regarded as a secondary reservoir for OXA-48 and NDM
carbapenemases [6, 7]. Indeed, the introduction of some
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OXA-48 and NDM expressing Enterobacteriaceae in
some European countries originated from hospital pa-
tients that were previously hospitalized in Egypt [8–11].
In view of the alarming increase in the appearance of
carbapenemase-producing bacteria in clinical isolates in
Egypt, a standard testing method should be used for
their detection to enable a suitable course of therapy to
be followed as part of an infection control program [12].
Molecular methods offer high sensitivity and specificity
and a rapid turnaround time. However, they cannot be
routinely used in countries with limited resources and a
high level of carbapenem resistance.
Phenotypic tests based on the inhibitory activity of bo-
ronic acid compounds are easy to perform and interpret.
Boronic acid compounds are serine-type-β-lactamase in-
hibitors that are not based on the β-lactam structure.
They are known as class C enzyme inhibitors. Boronic
acid tests using cefoxitin, cefotaxime, and ceftazidime
disks were used successfully detect AmpC enzymes [13].
Subsequently, boronic disk tests using carbapenems
have been proposed to be accurate phenotypic tests
for KPC [13, 14].
Because the value of the modified Hodge test (MHT)
and a boronic acid-based combined disk test for the de-
termination of widespread carbapenemase producers
(NDM-1and OXA-48) has been poorly documented our
study to used a collection of OXA-48 and NDM pro-
ducers as well as carbapenemase non-producers. The
aim of the present study was to examine the accuracy of
the MHT and a boronic acid-based combined disk test
using carbapenems as substrates in the phenotypic
determination of OXA-48 and NDM carbapenemases,
and to study the behavior of ESBL producers during
such tests. Additionally, we aimed to evaluate the per-
formance of a boronic acid combined disk test using
ceftazidime (30 μg) as well as two concentrations of
3-aminophenylboronic acid (APB; 300 and 600 μg), as




The present study was approved by the Faculty of Medi-
cine Cairo University Hospital, Egypt. Written informed
consent was not necessary for this retrospective study,
as it was part of our standard microbiological routine.
Patient data were anonymous for the purposes of this
analysis, and all confidential patient information was
protected in accordance with Egyptian law.
Hospital setting
The study was conducted at Cairo University Hospital,
which serves patients in Cairo (Egypt) and provides
medical and surgical care in all medical specialties. The
study took place from March to August 2013. The study
conforms to the relevant regulatory standards and is in
accordance with the recommendations of the Clinical
and Laboratory Standards Institute (CLSI) guidelines.
A total of 45 epidemiologically unrelated carbapenem
resistant K. pneumoniae, Acinetobacter baumanii, and
Pseudomonas aeruginosa isolates obtained from a surgi-
cal intensive care unit were included in the study. The
isolates included 32 carbapenemase producers {OXA-48
(n = 24), NDM (n = 8)}. The strains had been character-
ized previously by the polymerase chain reaction (PCR).
None of the isolates were KPC producers. To verify the
specificity of the methods for detecting OXA-48 and
NDM type carbapenemases, 13 carbapenem-resistant
GNBs (six A. baumanii, four P. aeruginosa, and three K.
pneumoniae isolates) were chosen for testing. All 13
isolates were negative for the blaOXA-48, blaNDM, and
blaKPC genes.
Antimicrobial susceptibility of isolates, and screening of
phenotypes
A detailed antimicrobial (IMP, meropenem, cefoxitin,
ceftazidime, cefpodoxime, ceftriaxone, amikacin, gen-
tamicin, trimethoprim–sulfamethoxazole, polymyxin
B, colistin, tigecycline, and fluoroquinolones (Becton
Dickinson, Sparks, MD, USA) susceptibility analysis
was conducted using the disc diffusion method ac-
cording to CLSI guidelines.
Phenotypes of detected ESBLs
ESBL screening was conducted via the disk diffusion test
using ceftazidime (30 μg) and cefpodoxime (10 μg) in ac-
cordance with CLSI guidelines. Confirmation of the
ESBL phenotype was determined using the double syn-
ergy test according to CLSI guidelines [15].
Phenotypic detection of ambler class C β-lactamase
Resistance to cefoxitin (30 μg) was used for the pre-
sumptive identification of AmpC β-lactamase [16].
Boronic acid disk tests
The isolates were suspended and diluted in normal sa-
line to 108 colony-forming units (CFU)/ml by compari-
son with a McFarland 0.5 turbidity standard, and spread
onto Mueller–Hinton agar plates (Mast Diagnostics,
Merseyside, UK) as recommended by the CLSI. The
following disks (Mast Diagnostics) were tested: IMP
(10 μg), IMP (10 μg) with APB (300 μg), meropenem
(10 μg), meropenem (10 μg) with APB (300 μg), ceftazi-
dime (30 μg), ceftazidime (30 μg) with APB (300 μg),
IMP (10 μg), IMP (10 μg) with APB (600 μg), merope-
nem (10 μg), meropenem (10 μg) with APB (600 μg),
ceftazidime (30 μg), and ceftazidime (30 μg) with APB
(600 μg). APB (Sigma-Aldrich, St. Louis, MO, USA) was
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dissolved in water at 50 mg/ml, and 6 and 12 μl (for the
300 and 600 μg concentrations, respectively) was applied
per disk. A 5-mm difference in zone diameter was used
as a cutoff to identify resistant isolates [14].
The MHT
The MHT was performed to confirm the production of
carbapenem-hydrolyzing β-lactamases in accordance with
CLSI guidelines. MHT Positive Klebsiella pneumoniae
ATCC1705 and MHT Negative Klebsiella pneumoniae
ATCC1706 were used as quality control for the test.
Detection of resistance genes
PCR amplification was used to detect carbapenemase
genes (blaKPC, blaNDM, and blaOXA-48) using previously
described primers and methodology [17–19].
Mass spectrometry
A pure, single colony was directly deposited on a
matrix-assisted laser desorption/ionization time-of-flight
(MALDI-TOF), reusable, polished steel target plate
(Bruker Daltonik GmbH, Bremen, Germany), and one
such deposit was made for each isolate. The preparation
was overlaid with 1 μL of matrix solution (a saturated
solution of α-cyano-4-hydroxycinnamic acid powder
dissolved in a standard solvent: 50 % acetonitrile, 2.5 %
trifluoroacetic acid, and 47.5 % deionized water), and the
matrix-sample was crystallized in the analyte molecules
at room temperature and analyzed within 24 h. Mea-
surements were performed with a MALDI-TOF mass
spectrometer (Bruker Daltonik GmbH) using Bruker
MALDI Biotyper RTC (Real Time Classification) soft-
ware version 3.1. The 15 bacterial species exhibiting
peptidic patterns that were most similar to that of the
isolate were ranked by their identification score.
Criteria for the identification of isolate
We used the score values proposed by the manufacturer.
Meaning of score values (standard sample) and color of
range description symbols: 2.300–3.000, highly probable
species identification (+++) green); 2.000–2.299, secure
genus identification (probable species identification (++)
green); 1.700–1.999, probable genus identification ((+)
yellow); 1.699, unreliable identification ((–) red).
Statistical methods
Data were coded and entered using the statistical pack-
age SPSS Statistics for Windows, Version 21.0 (IBM
Corp., Armonk, NY, USA). Data was summarized using
frequency (count) and relative frequency (percentage)
for categorical data. To compare categorical data, a chi-
square (χ2) test was performed. An exact test was used
when the expected frequency was less than 5. The kappa
measure of agreement was used to determine the agree-
ment between measures. Sensitivity, specificity, positive
likelihood ratio (LR+), and negative likelihood ratio
(LR−), as well as their 95 % confidence intervals
(CIs), were calculated. P-values less than 0.05 were
considered to be statistically significant.
Results
Clinical isolates
Among the 45 carbapenem-resistant GNB isolates, 28
came from respiratory tract specimens (62.2 %), eight
from blood (17.8 %), five from wounds (11.1 %), and four
from urine (8.9 %) (Fig. 1). The most common routes of
infection of these organisms were ventilator-associated
pneumonia (62.2 %), followed by bloodstream infections
(17.8 %), fractures (11.1 %), and urinary tract infections
(8.9 %) (Fig. 2). The most common isolates were: A. bau-
mannii (20, 44.40 %), followed by K. pneumoniae (13,
28.90 %), and P. aeruginosa (12, 26.70 %) (Fig. 3). The
male:female ratio in this study was 1:1.36, with males
and females constituting 57.80 and 42.20 %, respectively,
of the patients (Fig. 4). The results of the antimicrobial
sensitivity tests were as follows: 20 % of the isolates were
sensitive to amikacin; 57.8 % were sensitive to polymyxin
B; 37.8 % were sensitive to tigecycline; 22 % were sensi-
tive to ceftazidime; 2.2 % were sensitive to trimetho-
prim–sulfamethoxazole; 2.2 % were resistant to all tested
antibiotics; 86.66 % were resistant to cefoxitin; and
100 % were resistant to IMP, meropenem, ceftazidime,
cefpodoxime, ceftriaxone, and gentamicin. All isolates
met the ESBL screening and confirmatory test criteria,
as they demonstrated reduced susceptibility to ceftazidime
(30 μg) and cefpodoxime (10 μg) and yielded positive
results in the double-disk synergy test.
Phenotypic detection of OXA-48 producers
The results of the MHT are summarized in Table 1. The
MHT was positive for 19 OXA-48-producing clinical
Fig. 1 The distribution of specimens in the study; BAL: bronchoalveolar
lavage; ETA: endotracheal aspirate
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isolates, thus confirming the presence of significant
carbapenem-hydrolyzing activity. Five of the OXA-48
isolates yielded negative results with the MHT
(79.17 % sensitivity). All non-carbapenemase pro-
ducers yielded negative results with the MHT (100 %
specificity) (Table 1).
Boronic disk test
The results using the boronic disk test are summarized in
Table 2. Twenty OXA-48-producing isolates tested posi-
tive using the boronic disk test (using meropenem and
600 μg of APB). Four of the 24 OXA-48 isolates yielded
negative results with the boronic disk test (87.50 % sensi-
tivity). Three of the carbapenemase non-producers yielded
false-positive results with the boronic disk test (using IMP
and 300 μg of APB). The highest sensitivity (83.33 %) was
noted when using meropenem with 600 μg of APB. The
highest specificity (76.92 %) was observed when using
IMP with 300 μg of APB (Table 2).
Phenotypic detection of NDM producers
Seven NDM-producing clinical isolates tested positive
using the MHT, thus confirming the presence of signifi-
cant carbapenem-hydrolyzing activity. One of the eight
NDM isolates yielded negative results with the MHT
(87.50 % sensitivity). All of the carbapenemase non-
producers yielded negative results with the MHT (100 %
specificity) (Table 3).
Boronic acid disk test
Seven NDM-producing isolates tested positive using the
boronic acid disk test. One of the eight NDM-producing
isolates yielded negative results with the boronic acid
disk test (87.5 % sensitivity). Three of the non-
carbapenemase producers yielded false-positives with
the boronic acid disk test (IMP with 300 μg of APB)
(76.92 % specificity). The highest sensitivity (87.50 %)
was noted using meropenem with 300 μg of APB,
meropenem with 600 μg of APB, and IMP with
600 μg of APB (Table 4).
Phenotypic detection of AmpC enzyme producers using
the boronic disk test
Of the 45 carbapenem resistant GNB, 39 (86.66 %) were
phenotypically identified as AmpC producers by ceftazi-
dime screening. Boronic acid disk tests using ceftazidime
as a substrate were positive for 29 and 33 of the
Fig. 2 The clinical diagnosis associated with the isolates; BSI: blood
stream infection; UTI: urinary tract infection; VAP: ventilator
associated pneumonia
Fig. 3 The distribution of isolates in the study; the commonest were
Acinetobacter baumannii isolates: 20 (44.40 %), followed by Klebsiella
pneumoniae: 13 (28.90 %), and Pseudomonas aeruginosa 12 (26.70 %)
Fig. 4 The gender distribution in this study male 57.80 % and
female 42.20 %
Table 1 Results of MHT and boronic acid disk test for the
phenotypic detection of OXA-48 producers
OXA-48 producers MHT BA disk test
Positive Negative Positive Negative
Acinteobacter baumannii (11) 9 2 10 1
Pseudomonas aeruginosa (6) 4 2 3 3
Klebisella pneumoniae (7) 6 1 7 0
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Fox-resistant isolates when using 300 and 600 μg of
APB, respectively (sensitivities of 74.36 and 84.36 %,
respectively). None of the Fox-sensitive isolates yielded
positive results with the test (100 % specificity)
(Table 5).
Discussion
OXA-48 and NDM enzymes have become increasingly
prevalent among GNB isolates in North Africa and the
Middle East [7, 8]. Given the limited therapeutic options
available, the accurate detection of these enzymes is the
crucial first step in controlling their spread and ensuring
optimal clinical outcomes. Real-time or multiplex PCR
analyses may accurately identify such isolates, but these
methods are not suitable for daily testing in clinical la-
boratories because of their high cost and inconvenience
[20]. Thus, simple, cost-effective techniques have been
sought. In the current study, the MHT and a boronic
acid disk test were tested against a collection of GNB
clinical isolates, some of which tested positive and nega-
tive for OXA-48 and NDM using PCR as the standard.
The MHT and boronic acid disk tests have been re-
ported to be accurate assays for the phenotypic detection
of KPC carbapenemases [13, 20–22]. However, for car-
bapenemases other than KPCs, the data regarding the
utility of these tests are unsatisfactory [23]. Regarding
the MHT, studies have come to contrasting conclusions,
with some showing it to be inadequate for detecting
metallo-β-lactamases [5] and OXA-48 [23], while others
showed that the MHT produces false-positive results for
carbapenemases [3, 5]. The CLSI published a recom-
mendation that stated that Enterobacteriaceae with ele-
vated carbapenem minimum inhibitory concentrations
or reduced disk diffusion inhibition zones should be
tested for carbapenemase production using the MHT;
however, this recommendation does not include P.
aeruginosa [24].
Boronic acid compounds have been shown to be excel-
lent AmpC inhibitors [13] Subsequently, they have been
shown to be excellent KPC inhibitors [24]. In the
present study, we evaluated the use of boronic acid disk
tests for the phenotypic detection of OXA-48- and
NDM-producing GNB isolates in the clinical laboratory.
The inhibitory activity of APB (300 and 600 μg) with
IMP and meropenem as antibiotic substrates was tested
against a collection of clinical isolates.
The clinical isolates included 32 carbapenemase
producers (24 OXA-48 producers and eight NDM pro-
ducers) and 13 carbapenemase non-producers. For the
24 OXA-48 producers, the sensitivity of the MHT was
79.17 %; the average reported sensitivity of the MHT is
>90 % [22]. The low sensitivity in our study could be at-
tributed to the fact that two P. aeruginosa isolates and
two A. baumannii isolates were not detected by the
MHT, or to the failure of the MHT to detect carbapene-
mase activity in two P. aeruginosa isolates and two A.
baumannii isolates, as well as in one K. pneumoniae iso-
late. This is in accordance with a report by Pasteran et
al. [25], who stated that the MHT is not suitable for de-
tecting carbapenemase production in P. aeruginosa, as
the reported sensitivity and specificity were 78 and 57 %,
respectively. Furthermore, a study in India concluded
that the MHT is not preferred for carbapenemase
detection in non-fermenting GNB. Moreover, the CLSI
recommendation for the MHT applies to all Enterobacte-
riaceae, except P. aeruginosa [24]. For the eight NDM
producers, the MHT was positive, except for one A.
baumannii isolate (87.50 % sensitivity). All carbapene-
mase non-producing species yielded negative results
with the MHT (100 % specificity).
In the current study, boronic acid disk tests using IMP
and meropenem as antibiotic substrates, with 300 and
600 μg of APB, demonstrated variable results regarding
the differentiation of carbapenemase producers. For the
24 OXA-48 isolates, the boronic acid disc test was posi-
tive for 20 isolates using meropenem as a substrate with
600 μg of PBA. Five isolates (two A. baumannii isolates,
Table 2 Summary of sensitivities, specificities, positive and negative predictive values of the boronic acid disk test using different
antibiotic substrates with different concentrations of APB, for the phenotypic detection of OXA-48 producers
Antibiotic used in boronic
acid disk test




OXA-48 (n = 13)




IPM 300 17 3 70.8 % 76.92 % 85 % 58.82 %
MEM 300 18 8 75 % 38.46 % 69.23 % 45.45 %
IPM 600 19 8 79.17 % 38.46 % 70.37 % 50 %
MEM 600 20 9 83.33 % 30.77 % 68.97 % 50 %
Table 3 Results of MHT and boronic acid disk test for the
phenotypic detection of of NDM producers
OXA-48 producers MHT BA disk test
Positive Negative Positive Negative
Acinetobacter baumannii (3) 2 1 3 0
Pseudomonas aeruginosa (3) 2 1 3 0
Klebisella pneumoniae (2) 2 0 1 1
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two P. aeruginosa isolates, and one K. pneumoniae iso-
lates) yielded false-negative results. All of the other K.
pneumoniae, P. aeruginosa, and A. baumannii isolates
were accurately identified. The highest sensitivity
(83.33 %) was obtained using a meropenem disk com-
bined with 600 μg of APB. The boronic disk test was
positive for all NDM-producing isolates, except one A.
baumannii isolate (87.50 % sensitivity), and all of the
other K. pneumoniae, P. aeruginosa, and A. baumannii
isolates were accurately identified. False-positive results
were observed for carbapenemase non-producers using
the boronic acid disk test. The highest specificity
(76.92 %) was achieved using an IMP disk with 300 μg
of APB. False-positive results among these isolates could
be attributed to the concomitant production of the
AmpC β-lactamase (12 of the 13 carbapenemase non-
producers were AmpC producers). This is in accordance
with the results of Giske et al. [26] who attributed the
false-positive results of the boronic acid disk test in their
isolates to AmpC production, coupled with porin loss.
ESBL production was detected in 100 % of our iso-
lates. This is in accordance with the results obtained in
Egypt by Zafer et al. [27], who found that 100 % of
multidrug-resistant Enterobacteriaceae isolates were
ESBL producers. Overall, the boronic acid disk test using
meropenem as a substrate with 600 μg of APB was the
most sensitive method (83.33 %) for the detection of
OXA-48, while the most specific method was the MHT
(100 %). Concerning NDM carbapenemase, the boronic
acid disk test using IMP with 600 μg of APB, and mero-
penem with 300 or 600 μg of APB were the most sensi-
tive methods (87.50 % each), while the most specific
method was the MHT (100 %). Nevertheless, the MHT
and boronic acid disk test are convenient assays for the
initial screening of potential OXA-48 and NDM pro-
ducers among carbapenem-resistant GNB [13, 14]. How-
ever, the validity of such tests in non-fermenters needs
to be confirmed.
The boronic acid test using disks of ceftazidime with
600 μg of APB was also sensitive and specific for the
detection of AmpC producers (sensitivity, 84.36 %; spe-
cificity, 100 %). This result is in accordance with a study
by Coudron et al. [16], who stated that the boronic acid
disk test is a simple and efficient method for detecting
plasmid-mediated AmpC production. Furthermore, the
boronic acid disk test also enhanced the detection of iso-
lates that harbored both ESBLs and AmpC β-lactamases,
which was also the case in our study. However, this test
failed to detect AmpC production in six resistant isolates
(five AmpC-producing P. aeruginosa isolates and one
AmpC-producing K. pneumoniae isolate). For the other
K. pneumoniae, A. baumannii, and P. aeruginosa iso-
lates, AmpC production was accurately detected using
ceftazidime and 600 μg of APB (97.05 % sensitivity). This
finding is in accordance with a report by Upadhyay et al.
[28], who evaluated several inhibitor-based methods for
the detection of AmpC production in P. aeruginosa,
none of which could detect all of the AmpC variants of
clinical importance. They undertook a study using a var-
iety of inducers and inhibitors, including the boronic
acid inhibition test, and the sensitivity was 43 %.
In recent years, Egypt has been among the countries
with the highest reported rates of antimicrobial resist-
ance [27]. Plasmid-mediated, AmpC-producing isolates
are frequently detected (86.66 % of the isolates in the
current study), and in several cases they contribute to
reduced susceptibility to carbapenems, which was ob-
served among AmpC producers that did not harbor
Table 4 Summary of sensitivities, specificities, positive and negative predictive values of the boronic acid disk test using different
antibiotic substrates with different concentrations of APB, in the phenotypic detection of NDM producers
Antibiotic used in boronic
acid disk test




NDM (n = 13)




IPM 300 6 3 75 % 76.92 % 66.67 % 83.33 %
MEM 300 7 8 87.5 % 38.46 % 46.67 % 83.33 %
IPM 600 7 8 87.5 % 38.46 % 46.67 % 83.33 %
MEM 600 7 9 87.5 % 30.77 % 43.75 % 80 %
Table 5 Results of boronic acid disk tests using ceftazoidime (CAZ) as substrate with either 300 or 600 μg of APB in the phenotypic
detection of Amp C
For screening Test performance
FOX resistant (n = 31) FOX sensitive (n = 6) Sensitivity Specificity PPV NPV
+ve by boronic acid -ve by boronic acid +ve by boronic acid -ve by boronic acid
CAZ 300 29 10 0 6 74.36 % 100 % 100 % 37.5 %
CAZ 600 33 6 0 9 84.67 % 100 % 100 % 50 %
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carbapenemase-encoding genes, as determined by PCR, in
the present study; this finding is also supported by a study
by Noyal et al. [29]. Our study is limited by the relatively
small number of isolates assessed. However, replicating
the study using a large number of diverse samples of
OXA-48 and NDM producers and non-producers will
help to establish the reliability of these tests.
Conclusions
The results of this study clearly demonstrate that pheno-
typic screening with the MHT and boronic acid disk test
may have an important role in the detection of OXA-48
and NDM carbapenemases in GNB clinical isolates, and
these tests, which are cost-effective, can be easily applied
in any tertiary care settings with minimal infrastructure.
Routine testing of all carbapenem-resistant clinical iso-
lates for possible carbapenemase activity may increase
the availability of data for such isolates, as only a few
studies have examined this phenomenon. Confirmation
of the resistance mechanism is not required from a
public health perspective.
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